target directory

alpha 1 antitrypsin deficiency aatd associated lung disease utilizing aav and crispr cas9 gene editing technology clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.